Literature DB >> 29313159

Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.

Jiaxuan Zhang1,2, Wenzhen Zhu1, Rongwen Tain2,3, Xiaohong Joe Zhou4,5,6,7, Kejia Cai8,9,10.   

Abstract

PURPOSE: The purpose of the study is to demonstrate the value of quantitative amide proton transfer (APT) imaging for differentiating glioma grades and detecting tumor proliferation. PROCEDURES: This study included 32 subjects with 16 low-grade gliomas (LGG) and 16 high-grade gliomas (HGG) confirmed by histopathology. Chemical exchange saturation transfer (CEST) magnetic resonance imaging with APT weighting was performed on a 3 T scanner. After B0 correction, Z-spectra were fitted with Lorentzian functions corresponding to the upfield semi-solid magnetization transfer and nuclear overhauser enhancement (MT&NOE) effect, the direct saturation (DS) effect, and the downfield APT effect centered at around - 1.5, 0, and + 3.5 ppm, respectively. To compute the Z-spectral fitted APT (fitted_APT) in solid tumor tissue, double-peak histogram fitting of pixel MT&NOE effect from the whole tumor was used to remove necrosis regions. The fitted APT was then compared with the conventional APT based on magnetization transfer ratio asymmetry. Receiver operating characteristic (ROC) analysis was used to compare the performance between Z-spectral fitted contrasts and the con_APT for LGG versus HGG differentiation. Additionally, the correlations between the imaging contrasts (fitted_APT, con_APT, and fitted_MT&NOE) and Ki-67 labeling index for tumor proliferation were also evaluated.
RESULTS: Z-spectral fitted_APT shows improved statistical power for differentiating HGG and LGG (7.58 ± 0.99 vs. 6.79 ± 1.05 %, p < 0.05) than con_APT (4.34 ± 0.95 vs. 4.05 ± 2.02 %, p > 0.05) in solid tumor tissues. Analyses of whole tumor, on the other hand, have less differentiating power for both fitted_APT (p from 0.032 to 0.08) and con_APT (p from 0.696 to 0.809). Similarly, based on ROC analyses, fitted_APT shows larger area under the curve (AUC = 0.723) than con_APT (AUC = 0.543). The combination of fitted APT, DS, and MT&amp;NOE further improved the specificity (75 %), diagnostic accuracy (78.2 %), and area under the curve (0.758) in differentiating LGG and HGG. Consistently, fitted_APT (r = 0.451, p = 0.018) is better correlated with Ki-67 than con_APT (r = 0.331, p = 0.092).
CONCLUSIONS: Fitted APT from Z-spectrum improves differentiation of low- and high-grade gliomas and better correlated with tumor proliferation than conventional APT.

Entities:  

Keywords:  APT contrast; Glioma; Ki-67 labeling index; Tumor proliferation; Z-spectrum

Mesh:

Substances:

Year:  2018        PMID: 29313159     DOI: 10.1007/s11307-017-1154-y

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  38 in total

1.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semisolid magnetization transfer reference (EMR) signals: II. Comparison of three EMR models and application to human brain glioma at 3 Tesla.

Authors:  Hye-Young Heo; Yi Zhang; Shanshan Jiang; Dong-Hoon Lee; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-05-28       Impact factor: 4.668

Review 2.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

3.  Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

Authors:  Yusuhn Kang; Seung Hong Choi; Young-Jae Kim; Kwang Gi Kim; Chul-Ho Sohn; Ji-Hoon Kim; Tae Jin Yun; Kee-Hyun Chang
Journal:  Radiology       Date:  2011-10-03       Impact factor: 11.105

4.  Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T.

Authors:  Xuna Zhao; Zhibo Wen; Fanheng Huang; Shilong Lu; Xianlong Wang; Shuguang Hu; Donglin Zu; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2011-03-10       Impact factor: 4.668

Review 5.  Assessment of glioma proliferation using imaging modalities.

Authors:  George A Alexiou; Spyridon Tsiouris; Athanasios P Kyritsis; Maria I Argyropoulou; Spyridon Voulgaris; Andreas D Fotopoulos
Journal:  J Clin Neurosci       Date:  2010-07-16       Impact factor: 1.961

6.  Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T.

Authors:  Craig K Jones; Alan Huang; Jiadi Xu; Richard A E Edden; Michael Schär; Jun Hua; Nikita Oskolkov; Domenico Zacà; Jinyuan Zhou; Michael T McMahon; Jay J Pillai; Peter C M van Zijl
Journal:  Neuroimage       Date:  2013-04-06       Impact factor: 6.556

7.  Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.

Authors:  Hye-Young Heo; Craig K Jones; Jun Hua; Nirbhay Yadav; Shruti Agarwal; Jinyuan Zhou; Peter C M van Zijl; Jay J Pillai
Journal:  J Magn Reson Imaging       Date:  2015-12-10       Impact factor: 4.813

8.  Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histology.

Authors:  Daniel Paech; Sina Burth; Johannes Windschuh; Jan-Eric Meissner; Moritz Zaiss; Oliver Eidel; Philipp Kickingereder; Martha Nowosielski; Benedikt Wiestler; Felix Sahm; Ralf Omar Floca; Jan-Oliver Neumann; Wolfgang Wick; Sabine Heiland; Martin Bendszus; Heinz-Peter Schlemmer; Mark Edward Ladd; Peter Bachert; Alexander Radbruch
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

Review 9.  An overview of CEST MRI for non-MR physicists.

Authors:  B Wu; G Warnock; M Zaiss; C Lin; M Chen; Z Zhou; L Mu; D Nanz; R Tuura; G Delso
Journal:  EJNMMI Phys       Date:  2016-08-26

10.  Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation.

Authors:  Rifeng Jiang; Jingjing Jiang; Lingyun Zhao; Jiaxuan Zhang; Shun Zhang; Yihao Yao; Shiqi Yang; Jingjing Shi; Nanxi Shen; Changliang Su; Ju Zhang; Wenzhen Zhu
Journal:  Oncotarget       Date:  2015-12-08
View more
  18 in total

Review 1.  Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Koji Takumi; Yuichi Kumagae; Yoshihiko Fukukura; Takashi Yoshiura
Journal:  Jpn J Radiol       Date:  2018-10-19       Impact factor: 2.374

2.  CEST MRI quantification procedures for breast cancer treatment-related lymphedema therapy evaluation.

Authors:  Rachelle Crescenzi; Paula M C Donahue; Helen Mahany; Sarah K Lants; Manus J Donahue
Journal:  Magn Reson Med       Date:  2019-10-21       Impact factor: 4.668

3.  Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging.

Authors:  Lu Yu; Chunmei Li; Xiaojie Luo; Jinyuan Zhou; Chen Zhang; Yi Zhang; Min Chen
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

4.  Endogenous Chemical Exchange Saturation Transfer MRI for the Diagnosis and Therapy Response Assessment of Brain Tumors: A Systematic Review.

Authors:  Sachi Okuchi; Ahmed Hammam; Xavier Golay; Mina Kim; Stefanie Thust
Journal:  Radiol Imaging Cancer       Date:  2020-01-31

5.  Characterization of microenvironmental changes in the intervertebral discs of patients with chronic low back pain using multiparametric MRI contrasts extracted from Z-spectrum.

Authors:  Li Li; Zhiguo Zhou; Wei Xiong; Jicheng Fang; Alessandro Scotti; Mehran Shaghaghi; WenZhen Zhu; Kejia Cai
Journal:  Eur Spine J       Date:  2021-01-21       Impact factor: 3.134

6.  Effect of changes in the menstrual cycle and age on the signal intensity of amide proton transfer imaging in the normal uterus: a preliminary study.

Authors:  Ya-Qing Kong; Qian-Qian Qu; Lei Ming; Zhe Wang; Xiao-Tong Chi; Kai Deng
Journal:  Abdom Radiol (NY)       Date:  2022-09-13

7.  Glutamate-Weighted CEST Contrast After Removal of Magnetization Transfer Effect in Human Brain and Rat Brain with Tumor.

Authors:  Ayan Debnath; Hari Hariharan; Ravi Prakash Reddy Nanga; Ravinder Reddy; Anup Singh
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

8.  Amide proton transfer-weighted MRI for predicting histological grade of hepatocellular carcinoma: comparison with diffusion-weighted imaging.

Authors:  Yue Lin; Xiaojie Luo; Lu Yu; Yi Zhang; Jinyuan Zhou; Yuwei Jiang; Chen Zhang; Jintao Zhang; Chunmei Li; Min Chen
Journal:  Quant Imaging Med Surg       Date:  2019-10

9.  CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing.

Authors:  Laura Mancini; Stefano Casagranda; Guillaume Gautier; Philippe Peter; Bruno Lopez; Lewis Thorne; Andrew McEvoy; Anna Miserocchi; George Samandouras; Neil Kitchen; Sebastian Brandner; Enrico De Vita; Francisco Torrealdea; Marilena Rega; Benjamin Schmitt; Patrick Liebig; Eser Sanverdi; Xavier Golay; Sotirios Bisdas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-14       Impact factor: 10.057

10.  In Vivo Proton Exchange Rate (kex ) MRI for the Characterization of Multiple Sclerosis Lesions in Patients.

Authors:  Haiqi Ye; Mehran Shaghaghi; Qianlan Chen; Yan Zhang; Sarah E Lutz; Weiwei Chen; Kejia Cai
Journal:  J Magn Reson Imaging       Date:  2020-09-24       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.